CD200 expression predicts poor prognosis in neuroblastoma: a potential biomarker for treatment stratification—a retrospective cohort study
Topic overview
Retrospective study identifying CD200 expression as a prognostic biomarker in neuroblastoma patients, with potential implications for risk stratification and treatment planning in pediatric oncology.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. CD200 expression predicts poor prognosis in neuroblastoma: a potential biomarker for treatment stratification—a retrospective cohort study. GlobalCastMD Medical Library. 2026-01-22. https://library.globalcastmd.com/article/11412
Comments